XML 64 R24.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segments | 12 Months Ended
--- | ---
Dec. 31, 2013
Segments [Abstract] |
Segment Reporting Disclosure [Text Block] | Segments Beginning with the acquisition of MTS, which was completed on May 21, 2012, we have organized our business into two operating business segments: Acute Care, which primarily includes products and services sold to hospital customers and Non-Acute Care, which primarily includes products and services sold to customers outside of hospital settings. The Acute Care segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems. The Non-Acute Care segment includes primarily the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services, but also includes medication dispensing systems sold to non-acute care pharmacies and facilities. We report segment information based on the management approach. The management approach designates the internal reporting used by the Chief Operating Decision Maker (the "CODM") for making decisions and assessing performance as the source of our operating segments. The CODM is our Chief Executive Officer. The CODM allocates resources to and assesses the performance of each operating segment, using information about its revenues, gross profit and income (loss) from operations. Since 1992, Omnicell has provided automation and business information solutions to acute care hospitals. We have developed product solutions that help optimize various workflows utilized in hospitals. We have also developed sophisticated sales, installation, and service capabilities to serve the specific and special needs of the acute care environment in hospitals. As the acute care market evolves, we see opportunities to provide medication adherence solutions, which were added to our product line through the acquisition of MTS, to the acute care market as well. A portion of our organization structure and management processes will continue to be structured to optimize sales and service of solutions to the acute care market. Since 1984, MTS has provided medication adherence solutions to the non-acute care market. These solutions provide automated and semi-automated equipment to assist institutional and retail pharmacists in filling medication orders into blister cards, the primary method of medication control in non-acute care settings. Completing the product solution are the consumables used by institutional and retail pharmacists to make the medication adherence package. MTS has developed process manufacturing capabilities as well as sales capabilities to market medication adherence solutions to institutional and retail pharmacies. A portion of our organization structure and management processes will continue to be structured to optimize the product, sales, and service of solutions to the non-acute care market. In 2012, we realigned our management reporting structure to report sales of Omnicell's dispensing systems and other related business transactions into long-term care pharmacies and facilities. Accordingly, the operations of this portion of our activities are now being reflected as a part of the Non-Acute Care segment for the year ended December 31, 2012 and 2013. The impact of this reporting structure change on the year ended December 31, 2011 was immaterial to our overall reported results. We believe that legislative changes and economic pressures to manage costs will cause healthcare organizations to manage the health of patients across the continuum of care regardless of the setting in which the care is provided. We believe we have the capabilities and market position to provide the tools needed by our customers to manage medications across the continuum of care. But we also believe that the inherent differences between medication management workflows in acute care settings and non-acute care settings will cause our product solutions and marketing strategies to be managed separately for these two customer segments. In the second quarter of 2013, our management changed its methodology for allocating certain expenses to our reportable segments. We have reclassified segment operating results for the years ended December 31, 2012 to conform to the 2013 presentation. For the years ended December 31, 2013, 2012 and 2011 the contributions of our segments to net revenues and income from operations, and the reconciliation to total net income, were as follows (amounts in thousands):
| December 31, |  | December 31, |  | December 31,
| 2013 |  | 2012 |  | 2011
| Acute Care |  | Non-Acute Care |  | Total |  | Acute Care |  | Non-Acute Care (1) |  | Total |  | Acute Care |  | Total
Net revenues from external customers | $ | 284,666 |  |  | $ | 95,919 |  |  | $ | 380,585 |  |  | $ | 260,160 |  |  | $ | 53,867 |  |  | $ | 314,027 |  |  | $ | 245,535 |  |  | $ | 245,535 |
Cost of revenues | 122,816 |  |  | 54,370 |  |  | 177,186 |  |  | 111,599 |  |  | 31,840 |  |  | 143,439 |  |  | 109,751 |  |  | 109,751 |
Gross profit | $ | 161,850 |  |  | $ | 41,549 |  |  | $ | 203,399 |  |  | $ | 148,561 |  |  | $ | 22,027 |  |  | $ | 170,588 |  |  | $ | 135,784 |  |  | $ | 135,784 |
Gross margin % | 56.9 | % |  | 43.3 | % |  | 53.4 | % |  | 57.1 | % |  | 40.9 | % |  | 54.3 | % |  | 55.3 | % |  | 55.3 | %
Operating expenses | 131,811 |  |  | 36,289 |  |  | 168,100 |  |  | 127,467 |  |  | 15,995 |  |  | 143,462 |  |  | 119,562 |  |  | 119,562 |
Income from operations | $ | 30,039 |  |  | $ | 5,260 |  |  | $ | 35,299 |  |  | $ | 21,094 |  |  | $ | 6,032 |  |  | $ | 27,126 |  |  | $ | 16,222 |  |  | $ | 16,222 |
Operating margin % | 10.6 | % |  | 5.5 | % |  | 9.3 | % |  | 8.1 | % |  | 11.2 | % |  | 8.6 | % |  | 6.6 | % |  | 6.6 | %
Interest and other income (expense), net |  |  |  |  | (270 | ) |  |  |  |  |  | (51 | ) |  |  |  | (133 | )
Income before provision for income taxes |  |  |  |  | 35,029 |  |  |  |  |  |  | 27,075 |  |  |  |  | 16,089 |
Provision for income taxes |  |  |  |  | 11,050 |  |  |  |  |  |  | 10,897 |  |  |  |  | 5,700 |
Net income |  |  |  |  | $ | 23,979 |  |  |  |  |  |  | $ | 16,178 |  |  |  |  | $ | 10,389 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the closing date of acquisition.
At December 31, 2013, 2012, and 2011 segment assets, depreciation and amortization, and capital expenditures were as follows (amounts in thousands):
| December 31, |  | December 31, |  | December 31,
| 2013 |  | 2012 |  | 2011
| Acute Care |  | Non-Acute Care (1) |  | Total |  | Acute Care |  | Non-Acute Care (1) |  | Total |  | Acute Care |  | Total
Segment Assets | $ | 263,154 |  |  | $ | 229,347 |  |  | $ | 492,501 |  |  | $ | 235,186 |  |  | $ | 206,633 |  |  | $ | 441,819 |  |  | $ | 363,849 |  |  | $ | 363,849 |
Depreciation/Amortization | $ | 11,236 |  |  | $ | 7,129 |  |  | $ | 18,365 |  |  | $ | 9,017 |  |  | $ | 4,308 |  |  | 13,325 |  |  | 7,983 |  |  | 7,983 |
Capital Expenditures | $ | 4,392 |  |  | $ | 7,943 |  |  | $ | 12,335 |  |  | $ | 13,234 |  |  | $ | 1,953 |  |  | $ | 15,187 |  |  | $ | 8,685 |  |  | $ | 8,685 |
(1) Non-Acute Care segment includes MTS results from May 21, 2012, the date of acquisition.
For the year ended December 31, 2012, the Non-Acute Care cost of revenues included $1.7 million of acquisition-related charges primarily associated with the step-up to the estimated fair value of inventory acquired from MTS and consumed in the normal sales cycle of our business. The Non-Acute Care operating expenses included $0.9 million of acquisition-related charges primarily associated with severance expenses. For the year ended December 31, 2012, the Acute Care operating expenses included $2.3 million of acquisition-related charges for transaction costs, required to be expensed under ASC 805, Business Combinations.

X
- Details
Name: | omcl_SegmentsAbstract
Namespace Prefix: | omcl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration